Psychiatry/Behavioral · PANCE / PANRE

Specific Phobias

Marked, irrational fear cued by a specific object or situation, with avoidance and impairment ≥6 months.

Also known as: specific phobia, phobia, simple phobia

Overview

DSM-5-TR: marked fear or anxiety about a specific object or situation (e.g., animals, heights, blood/injection/injury, closed spaces, flying). The phobic stimulus almost always provokes immediate fear, is actively avoided or endured with intense distress, is out of proportion to the actual danger, and persists ≥6 months with significant impairment. Five specifier types: animal, natural environment, blood-injection-injury (BII), situational, other.

Epidemiology

12-month US prevalence ~7-9%; lifetime ~12-15%. Most common anxiety disorder. Female predominance ~2:1 except BII (more equal). Onset typically childhood (median ~7-10 yo); blood-injection-injury and situational often persist into adulthood.

🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Specific Phobias outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • First-degree family history (especially of same phobia subtype)
  • Direct traumatic experience or observational learning
  • Behavioral inhibition / negative affectivity temperament
  • Female sex
  • Childhood adversity

Pathophysiology

Conditioned amygdala-driven fear response. Genetic preparedness for evolutionarily salient threats (snakes, heights, blood). BII phobia uniquely associated with a biphasic vasovagal response: initial sympathetic surge followed by parasympathetic-mediated bradycardia and syncope.

Clinical presentation

Symptoms

  • Immediate intense fear/anxiety on exposure (or anticipation) of the phobic stimulus
  • Active avoidance of the trigger
  • Recognition that the fear is excessive (less reliable in children)
  • Physiologic symptoms during exposure: tachycardia, sweating, trembling, dyspnea, GI distress

Signs / physical exam

  • Sympathetic activation during exposure in most subtypes
  • BII subtype: vasovagal response — bradycardia, pallor, hypotension, syncope (often the presenting complaint)

Classic findings

Patient who consistently avoids flying despite job consequences, or faints at sight of blood during routine venipuncture.

Differential diagnosis

  • Social anxiety disorder — Fear is specifically of social evaluation, not the object/situation itself
  • Panic disorder with agoraphobia — Fear of escape difficulty or incapacitation; multiple situations, not single object
  • Obsessive-compulsive disorder — Avoidance driven by obsessions (contamination, harm) rather than direct fear of object
  • PTSD — Avoidance linked to a specific past traumatic event with reexperiencing and arousal symptoms
  • Separation anxiety disorder — Fear of separation from attachment figures, not of an object
  • Realistic fear / cultural belief — Fear proportionate to actual risk or culturally sanctioned

Diagnostic workup

Diagnostic criteria

DSM-5-TR: marked fear of specific object/situation, immediate, avoidance/endurance with distress, out of proportion, ≥6 months, impairment, not better explained by another disorder. Specify subtype.

Labs

  • Not routinely needed; clinical diagnosis

Imaging

  • Not indicated

Diagnostic algorithm

SubtypeExamplesOnsetKey feature
AnimalSpiders, dogs, snakesChildhoodMost common; often co-occurring phobias
Natural environmentHeights, storms, waterChildhoodMay overlap with situational
Blood-injection-injuryVenipuncture, injury, dentalChildhoodVasovagal syncope; treat with applied tension
SituationalFlying, elevators, enclosed spacesMid-20s peakBimodal onset; high functional impact
OtherChoking, vomiting, loud soundsVariableHeterogeneous
DSM-5-TR specific phobia subtypes — note unique vasovagal physiology of the blood-injection-injury type.

Treatment

First-line

  • Exposure-based CBT (in vivo, imaginal, or virtual reality) — highly effective; single-session exposure can be curative for many specific phobias
  • Graded exposure with response prevention is the gold standard

Second-line / adjunct

  • Short-acting benzodiazepine (lorazepam, alprazolam) for one-time situational use (e.g., MRI, flight) — does NOT cure the phobia and may impair learning during exposure
  • Beta-blocker before procedure for autonomic blunting
  • SSRIs generally not first-line; reserved for comorbid anxiety/depression

Complications

  • Avoidance of medical care (BII phobia → unvaccinated, delayed diagnosis, untreated dental disease)
  • Occupational restriction (flying phobia, driving phobia)
  • Comorbid mood and anxiety disorders
  • Substance use to manage anticipatory anxiety

PANCE pearls

  • Exposure therapy is more effective than any medication for specific phobia and can be completed in 1-5 sessions for many patients.
  • BII phobia is the only phobia with prominent vasovagal syncope — treat with applied tension, not relaxation alone.
  • Benzodiazepines used during exposure may blunt the new learning needed for extinction — use sparingly.
  • Children may not recognize fear as excessive; reliance on parental report and functional impact is essential.
  • Always ask about avoidance of healthcare — BII phobia is a major driver of missed care.

References

  • DSM-5-TR — American Psychiatric Association. DSM-5-TR. 2022.
  • NICE — National Institute for Health and Care Excellence. Generalised Anxiety Disorder and Panic Disorder in Adults: Management. CG113, 2011 (updated).
  • Wolitzky-Taylor 2008 — Wolitzky-Taylor KB et al. Psychological approaches in the treatment of specific phobias: a meta-analysis. Clin Psychol Rev 2008;28(6):1021-37.

Practice Psychiatry/Behavioral questions on FirstPassPA

Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start studying free → Browse all 514 diagnoses

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.